OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for April, 2018

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you.

2018-04-30 12:15Sermo's 'Yelp for drugs' platform chalks up 665K doctor reviews in just 1 year and more...
2018-04-30 00:15AbbVie's First Quarter: Trying to Replace Humira Sales and more...
2018-04-29 00:154 Huge Pharma Deals in 4 Months Is Just the Beginning and more...
2018-04-28 12:15UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis and more...
2018-04-28 00:15The hepatitis C duopoly and more...
2018-04-27 12:15Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy and more...
2018-04-27 00:15Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say and more...
2018-04-26 12:15Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra and more...
2018-04-26 00:15Amgen focuses on migraine launch as growth remains slow and more...
2018-04-25 12:15AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study and more...
2018-04-25 00:15Immunotherapies, biosimilars to dominate next week of earnings and more...
2018-04-24 12:15Biogen stock drops 2% after Q1 sales miss and more...
2018-04-24 00:15FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses and more...
2018-04-23 04:30Fresenius SE Walks Away from $4.3 Billion Takeover of Akorn and more...
2018-04-22 17:06IMPORTANT: Change to our daily newsletter
2018-04-22 04:30Bellicum Pharmaceuticals Rakes in $69 Million - Closes Public Offering and more...
2018-04-21 04:30Lessons learned from going live on Facebook with a branded drug and more...
2018-04-20 04:30FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy and more...
2018-04-19 04:30Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso and more...
2018-04-18 12:15Abbott shares down on shrinking Q1 profits and more...
2018-04-18 00:15Healthcare on the Hill - Transparent Health Care Pricing Act of 2018 (H. R. 4808) and more...
2018-04-17 12:15Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing and more...
2018-04-17 00:15Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer and more...
2018-04-16 12:15Boston Scientific acquires NVision Medical in $275m deal and more...
2018-04-16 01:32CP Weekly April 15 2018
2018-04-16 00:15We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated and more...
2018-04-15 00:15EpiPen shortages seen in Canada, UK but U.S. supply intact and more...
2018-04-14 00:15Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says and more...
2018-04-13 12:15Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device and more...
2018-04-13 00:15PCSK9s appear to be meeting less payer resistance and more...
2018-04-12 12:15Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma and more...
2018-04-12 00:15Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS and more...
2018-04-11 12:15Alexion buying Swedish biotech for $855 million to broaden rare disease pipeline and more...
2018-04-11 00:15Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study and more...
2018-04-10 12:15Pfizer heads to the Hudson, signs 20-year lease at posh new NYC headquarters and more...
2018-04-10 00:15FDA puts restrictions on Bayer birth control implant but no recall and more...
2018-04-09 12:15Celgene on biotech hunt with Agios, Jounce in crosshairs: FT and more...
2018-04-09 00:15Major restructuring with staff cuts in US for Teva and more...
2018-04-08 23:40CP Weekly April 8 2018
2018-04-08 12:15[video]Will Shire Be Bought Out? and more...
2018-04-07 12:15Abbott disputes ‘flawed and inaccurate’ proxy report over CEO’s pay and more...
2018-04-07 00:15Incyte's Horrible News Derails a Promising Class of Cancer Drugs and more...
2018-04-06 12:15Merck gets a lift, Pfizer a ding as analysts assess immuno-oncology, M&A outlook and more...
2018-04-06 00:15Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test and more...
2018-04-05 12:15Hopes rise for Shire sale as Takeda CEO discusses case for deal and more...
2018-04-05 00:15Amgen's money-back offer on Repatha isn't all that meaningful, researchers find and more...
2018-04-04 12:15Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib and more...
2018-04-04 00:15Will Blincyto's Expanded FDA Approval Open the Door for Wider Use of MRD as a Biomarker or Endpoint? and more...
2018-04-03 12:15Justice Dept. says it will seek to join settlement talks in opioid lawsuits and more...
2018-04-03 00:15Citizen Petition Watch - Increased Activity Around Ditropan XL and more...
2018-04-02 12:15Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise and more...

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe